“…According to such documents, appropriate surveillance indications may be given only after a high‐quality baseline colonoscopy. However, in clinical practice, post‐polypectomy surveillance recommendations could be made by clinicians who may not be very familiar with colonoscopy quality metrics, especially in the setting of organized screening programs . In addition, position statements addressing the quality of colonoscopy are generally skewed toward the concern of detection rather than surveillance, as adenoma detection rate and withdrawal time have been associated with the risk of post‐colonoscopy interval cancer, irrespective of post‐polypectomy surveillance.…”